Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transtympanic Lactate for Otoprotection in Chemotherapy
NCT01108601Phase 2Unknown
- Sponsor
- McGill University Health Centre
- Start
- Apr 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lactated ringer's solution in ototoxicity, sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
lactated ringer's solution
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT01108601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108601.